Enter your login e-mail to the account
Search
Search parameters
Search results
- ATRIAL FIBRILLATION IN GENERAL PRACTITIONER‘S PRACTICE AND VALUE OF RAAS INHIBITORS IN PREVENTION AND TREATMENT OF THIS ARRHYTHMIA
MUDr. Peter Jonáš, MUDr. Anton Farkaš
(12/2007, clearly ) - Rosuvastatín: nový inhibítor 3-hydroxy-3-methylglutaryl koenzým a reduktázy
doc. MUDr. Martin Gajdoš,CSc., MUDr. Ľubica Cibulová, RNDr. Zora Krivošíková, PhD.,
(1/2004, Medicine ) - Chyby a úskalí terapie statiny
MUDr. Lubor Goláň
(1/2004, Main topic ) - Pharmacological therapy of the heart failure
doc. MUDr. Peter Mitro, PhD.
(1/2009, Review articles ) - New possibilities in the pharmacotherapy of primary hypertension
MUDr. Viera Smetanová, PhD.
(2/2010, Review articles ) - Pharmacotherapy of rheumatoid arthritis II. – biological therapy
doc. MUDr. Želmíra Macejová, PhD., doc. MUDr. Ivan Rybár, PhD.
(2/2010, Drugs & drug classes ) - The role of targeted therapy in the treatment of renal cell carcinoma
doc. MUDr. Jozef Mardiak, CSc.
(11/2009, Review articles ) - Evolokumab pro léčbu familiární hypercholesterolémie
prof. MUDr. Vladimír Bláha, CSc.
(4/2018, Drugs & drug classes ) - Overview of results in selected pharmacoeconomic studies with valsartan
PharmDr. Tomáš Tesař, PhD., MBA, Mgr. Matúš Džupon, doc. PhDr. Róbert Babeľa, PhD., MBA
(11/2009, Pharmacoeconomics ) - Current perspective on treating erectile dysfunction in the general practitioner's surgery
MUDr. Pavel Turčan
(1/2016, Interdisciplinary consilium ) - Future of hypolipidemic therapy
MUDr. Fábryová Ľubomíra, PhD.
(5/2010, Topic of the year ) - Pohled na otázky kardiovaskulárního rizika moderních nesteroidních antirevmatik
MUDr. David Suchý
(4/2004, Spectrum ) - Efficiency and safety of linagliptin – relevance to clinical practice
doc. MUDr. Martin Prázný, CSc., Ph.D., MUDr. Jan Šoupal
(2/2014, Review articles ) - Combined hypolipidemic therapy in current clinical practice
MUDr. Ľubomíra Fábryová, PhD.
(6/2014, Review articles ) - DYSPHORIC DISORDER: RECOGNITION AN D THREATMENT
MUDr. Igor Lazar, prof. MUDr. Alexander Ostró, CSc.
(6/2006, Consilium ) - Overview of results in selected in pharmacoeconomic study of ACEi ramipril
PharmDr. Tomáš Tesař, PhD., MBA, Mgr. Matúš Džupon, doc. PhDr. Róbert Babeľa, PhD., MBA
(2/2009, Pharmacoeconomics ) - WHAT IS THE POSITION OF STATINS IN THE TREATMENT OF PATIENTS WITH HEART FAILURE?
prof. MUDr. Andrej Dukát, CSc., FESC, doc. MUDr. Ľudovít Gašpar, CSc.,, doc. MUDr. Jana Sirotiaková, CSc., MUDr. Peter Minárik
(9/2006, Main topic ) - Anticoagulant therapy in patients with atrial fibrillation
Doc. MUDr. Ján Kmec, PhD., MPH
(2/2017, Review articles ) - Neuropatická bolest – mechanizmus, příčiny a možnosti farmakoterapie
prof. MUDr. Zdeněk Ambler, DrSc.
(3/2009, Interdisciplinary consilium ) - Avascular necrosis of femoral head
MUDr. Boris Šteňo, PhD.
(3–4/2013, Interdisciplinary consilium ) - HIGH VIROLOGIC SUSTAINED RESPONSE TO FORMER YOUNG INTRAVENOUS DRUG ABUSERS WITH CHRONIC HEPATITIS C TREATED BY PEGYlATED INTERFERON – ALFA PLUS RIBAVIRIN (PRELIMINARY REPORT)
doc. MUDr. František Gazdík, doc. MUDr. Dušan Daniš CSc., RNDr. Kristína Fejdiová, MUDr. Michal Rastislav Piják, MUDr. Alexandra Mesárošová, MUDr. Ľubomír Okruhlica,, MUDr. Karol Laktiš, CSc., MUDr. Igor Stankovič, CSc., doc. MUDr. Katarína Gazdíková, PhD.
(10/2006, From practice ) - CHRONIC HEART FAILURE AND DIABETES MELLITUS
prof. MUDr. Jindřich Špinar, CSc., FESC., prof. MUDr. Jiří Vítovec, CSc.
(1/2005, Topic ) - Hepatocellular carcinoma in the ambulance of general practitioner
Doc. MUDr. Mária Belovičová, PhD.
(3/2015, Review articles ) - PERIPHERAL NERVE DISORDERS
prof. MUDr. Michal Drobný, DrSc.
(10/2007, Topic ) - Editoriál
MUDr. Zoltán Szép
(3/2005, Editorial ) - CURRENT VIEW OF PATHOGENESIS AND THERAPY OF ACNE
MUDr. Dušan Buchvald, PhD.
(3/2005, Topic ) - PHARMACOTHERAPY OF ARTERIAL HYPERTENSION IN PATIENTS WITH CORONARY HEART DISEASE
PharmDr. Lívia Magulová, PhD., h. doc. MUDr. Jana Sirotiaková, PhD., MUDr. Peter Minárik
(4-5/2008, clearly ) - THE POSSIBILITIES OF PREVENTION OF TYPE 2 DIABETES MELLITUS IN SUBJECTS WITH PREDIABETIC DYSGLYCEMIAS
prof. MUDr. Ivan Tkáč, PhD.
(10/2007, Supplement ) - PSORIASIS – NEWS IN PATHOGENESIS AND THERAPY
MUDr. Zoltán Szép
(3/2005, Topic ) - INCRETINS, INCRETIN EFFECT AND DIABETES MELLITUS
MUDr. Adriana Ilavská
(S4/2007, Supplement ) - Pharmacotherapy of chronic forms of ischemic limb disease according to current guidelines
MUDr. Jiří Holý, MUDr. Martin Holý, MUDr. Zsolt Keczkemethy, MUDr. Kamila Nováková, MUDr. Pavel Havránek
(3/2012, Review articles ) - THE POSSIBILITIES OF PREVENTION OF TYPE 2 DIABETES MELLITUS IN SUBJECTS WITH PREDIABETIC DYSGLYCEMIAS
prof. MUDr. Ivan Tkáč, PhD.
(S4/2007, Supplement ) - New possibilities of treatment of type 2 diabetes mellitus
MUDr. Vladimír Uličiansky, doc. MUDr. Zbynek Schroner, PhD.
(3-4/2014, Review articles ) - Chronic myeloid leukemia – model of successful targeted therapy of oncologic disease
doc. MUDr. Martin Mistrík, PhD., MUDr. Zuzana Sninská, PhD., MUDr. Antónia Hatalová, doc. MUDr. Angelika Bátorová, PhD
(3-4/2014, Interdisciplinary consilium ) - NON-OPIOID ANALGETICS IN THE TREATMENT OF CHRONIC PAIN
MUDr. Igor Martuliak, PhD.
(6/2005, Topic ) - POSSIBILITIES OF DIAGNOSIS AND TREATMENT OF LIPIDS DISORDERS IN AMBULANCE OF GENERAL PRACTITIONER
MUDr. Ľubomíra Fábryová
(6/2005, clearly ) - COXIBS IN RHEUMATOLOGY
doc. MUDr. Jozef Lukáč, CSc., prof. MUDr. Jozef Rovenský, DrSc., MUDr. Oľga Lukáčová, PhD.
(2/2005, Topic ) - POSITION OF ANGIOTENSIN 2-RECEPTOR BLOCKERS IN THE TREATMENTS OF ARTERIAL HYPERTENSION AND CURRENT MEDICINE
doc. MUDr. Marian Sninčák, PhD.
(1/2007, Topic ) - Fixed-dose combinations of calcium channel blockers and angiotensin-converting enzyme inhibitors in hypertension
MUDr. Slavomír Šuch
(3/2010, Drugs & drug classes ) - STATINS – DO THEY HAVE DOMINANT POSITION IN CARDIOVASCULAR PREVENTION? LIPID LOWERING AND PLEIOTROPIC EFFECTS OF STATINS
doc. MUDr. Daniel Pella, PhD., MUDr. Viola Vargová, PhD., MUDr. Ján Fedačko, MUDr. Richard Raši
(1/2007, clearly ) - COVID-19, ibuprofén, inhibítory angiotenzín-konvertujúceho enzýmu, sartany
MUDr. Mgr. Jaroslav Hrenák, PhD., MUDr. Kristína Repová, PhD.
(2/2020, Information & comments ) - IMMUNOMODULATORY EFFECTS OF STATINS
doc. MUDr. František Gazdík, PhD.
(5/2007, clearly ) - MANAGING DYSLIPIDAEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE
MUDr. Ľubomíra Fábryová
(10/2005, Topic ) - Gaps in quality and effectiveness of drug therapy of arterial hypertension: Use of central antihypertensive agents and alpha blockers in the treatment of arterial hypertension in the light of the 2018 ESC/ESH 2018 Guidelines for the management of arterial
MUDr. Tomáš Szalay, PhD., Mgr. Henrieta Tulejová, M.S., prof. MUDr. Robert Hatala, CSc., FESC, FACC, Ing. Mgr. Roman Mužik, PhD., Mgr. Kristína Halušťoková, MUDr. Ľuboš Urban, PhD., MUDr. Jana Bendová, PhD.
(3/2020, Original articles & case reports ) - Weight loss pharmacotherapy of obese non-diabetic and type 2 diabetic patients
MUDr. Ľubomíra Fábryová, PhD.
(6/2015, Topic of the year ) - Srovnání účinnosti semi-generického a originálního atorvastatinu
doc. MUDr. Richard Češka, CSc., prof. MUDr. Helena Vaverková, CSc., as. MUDr. Michal Vrablík, PhD., Jitka Housová, Tomáš Štulc, Željko Reiner, Zvonimir Rumboldt
(5/2005, Spectrum ) - Všeobecní lekári na Festivale kazuistík, Nižná 2018
MUDr. Peter Marko, MUDr. Viliam Chromý
(3/2018, Events ) - Sitagliptine – representative of the new group of drugs indicated in the treatment of type 2 diabetes mellitus
MUDr. Zbynek Schroner, PhD., MUDr. Vladimír Uličiansky
(4/2010, Drugs & drug classes ) - TREATMENT OF PATIENT WITH CONGESTIVE HEART FAILURE
prof. MUDr. Ján Murín, CSc.
(9/2006, Main topic ) - INCRETIN-BASED THERAPY IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS
MUDr. Zbynek Schroner, PhD., MUDr. Vladimír Uličiansky
(7-8/2008, Topic ) - ARE THE PROBLEMS OF THE TREATMENT OF PEPTIC ULCER DISEASE 23 YEARS AFTER DISCOVERING HELICOBACTER PYLORI SOLVED?
MUDr. Rudolf Hrčka, CSc.
(10/2006, Main topic ) - DIABETIC RETINOPATHY FROM AN OPHTHAMOLOGIC POINT OF VIEW
doc. MUDr. Vladimír Máliš, CSc., MUDr. Nikoleta Javorková, PhD.
(7-8/2008, Consilium ) - Diabetes and heart failure
prof. MUDr. Ján Murín, CSc., doc. MUDr. Jozef Bulas, CSc.
(1/2014, Review articles ) - Safety treatment with statins
prof. MUDr. RNDr. Rudolf Pullmann, PhD.
(1/2014, Review articles ) - Medications, natural substances, and dietary supplements in treating sexual dysfunctions: a sexologist’s perspective
MUDr. Ondřej Trojan
(1/2017, Electronic attachment ) - Depressive disorders in general practitioners practice – part I.
MUDr. Peter Marko
(10/2009, General Medicine ) - Triple therapy with protease inhibitors – new standard of care in chronic hepatitis C treatment
doc. MUDr. Pavol Kristian, PhD., prof. MUDr. Ivan Schréter, CSc., doc. MUDr. Peter Jarčuška, PhD.
(6/2011, Review articles ) - Use of biological treatment in oncology
MUDr. Michal Mego, MUDr. Lucia Masárová
(6/2011, Review articles ) - Do we treat asthma optimally? (Why do asthmatics exacerbate)
doc. MUDr. Martin Hrubiško, PhD.
(3/2011, Review articles ) - Benign prostatic hyperplasia, diagnostics and contemporary opportunities of miniinvasive treatment
MUDr. Jiří Klečka, Ph.D., MUDr. Petr Běhounek, doc. MUDr. Milan Hora, Ph.D., MUDr. Viktor Eret
(1/2011, Interdisciplinary consilium ) - OPTIMAL (TARGET) DOSING OF ACE INHIBITORS
doc. MUDr. Jana Sirotiaková, PhD., PhD., Peter Minárik
(12/2008, clearly )
- Recommendations for the treatment of unipolar depressive disorder
MUDr. Ľubica Forgáčová, PhD.
(4/2010, Recommendations for practice ) - Vortioxetine – the antidepressant with multimodal activity
doc. MUDr. Ján Pečeňák, CSc.
(1/2015, Psychopharmacology ) - Tobacco smoking and depression
MUDr. Michal Turček, PhD.
(2/2013, Review articles ) - Interactions of tobacco smoke with psychotropic medications
MUDr. Michal Turček, PhD.
(4/2011, Review articles ) - Current trends in the cognitive pharmacotherapy of Alzheimer´s disease
MUDr. Roman Jirák, CSc.
(2/2002, Review articles ) - Demention with Lewy’s Bodies, Diagnosis, Clinical Meaning, Treatment
MUDr. Jiří Konrád
(1/2004, Review articles ) - PHARMACOTHERAPY OF DEMENTIA
doc. MUDr. Vladimír Pidrman, Ph.D.
(5/2007, Review articles ) - Deprese jako vedlejší účinek terapie interferonem alfa u nemocných s chronickou hepatitidou C
MUDr. Jiří Syrovátka
(1/2005, Outpatient psychiatry ) - 16 16th th EUROPEAN CONGRESS OF PSYCHIATRY
MUDr. Dagmar Breznoščáková
(2/2008, News & comments ) - Nové trendy v léčbě obsedantně kompulzivní poruchy
MUDr. Pavla Stopková, Ph.D.
(2/2018, Review articles ) - PHARMACOLOGICAL INFLUENCE ON CRAVING
MUDr. Jela Hrnčiarová
(6/2004, Review articles ) - Friedrich Heinrich Lewy, his corpuscles and their illnesses
Prof. MUDr. Petr Kaňovský, CSc., MUDr. Kateřina Menšíková, Ph.D., prof. MUDr. Ing. Petr Hluštík, Ph.D.
(1/2017, Review articles ) - Treatment discontinuation in anxiety and depressive disorders
MUDr. Jiřina Kosová
(2/2004, Review articles ) - Dysthymia and its therapy
MUDr. Ján Praško, CSc. , MUDr. Erik Herman, doc. MUDr. Jiří Hovorka, CSc.
(6/2002, Review articles ) - Výzkum nových léčiv u Alzheimerovy choroby
PharmDr. Jana Hroudová, Ph.D.
(2/2018, Review articles ) - Sexual dysfunctions and longterm antidepressants intaken
MUDr. Luboš Janů, Ph.D.
(1/2001, Review articles ) - Long-term use of cognitive drugs in Alzheimer disease
MUDr. Vanda Franková
(4/2004, Review articles ) - Optimising treatment in Alzheimer’s disease
MUDr. Vanda Franková
(4/2016, Review articles ) - New perspectives in the treatment of bipolar affective disorder
MUDr. Iveta Fiziková, MUDr. Milena Drímalová, CSc.
(1/2013, Review articles ) - Combined therapy by Alzheimer´s disease
MUDr. Elena Žigová
(1/2013, Original articles & case reports ) - Dementia with Lewy bodies
doc. MUDr. Roman Jirák, CSc.
(1/2014, Digital publications ) - THE USE OF DUAL ANTIDEPRESSANTS IN THE TREATMENT OF DEPRESSIVE DISORDER
MUDr. Luboš Janů, Ph.D. , MUDr. Sylva Racková
(6/2008, Review articles ) - CHRONIC HEPATITIS C AND DEPRESSION – REDOUBTABLE COMBINATION?
MUDr. Mária Belovičová, PhD., dipl. s. Andrea Jašková, MUDr. Slávka Lenerová
(6/2008, Review articles ) - Neurochemical correlates of suicidal behavior
MUDr. Michal Patarák
(3/2014, Review articles ) - SSRI IN THE SPECTRUM OF ANXIETY DISORDERS
doc. MUDr. Vladimír Pidrman, Ph.D.
(1/2003, Review articles ) - Interdisciplinary approach in dementia treatment by cholinesterase inhibitors
doc. MUDr. Vladimír Pidrman, Ph.D., MUDr. Klára Látalová, doc. MUDr. Jiří Horáček, CSc.
(3/2003, Review articles ) - Antidepressant – indued sexual dysfunction
MUDr. Michal Maršálek, CSc.
(3/2003, Review articles ) - ANXIOLYTICS AND THEIR MECHANISM OF ACTION
MUDr. Martin Votava, PhD., Mgr. Viktoria Agová, prof. MUDr. Miloslav Kršiak, DrSc.
(3/2005, Review articles ) - THERAPEUTICAL APPROACHES IN BEHAVIORAL DISORDERS IN DEMENTIA
MUDr. Vanda Franková
(6/2007, Review articles ) - CURRENT TRENDS IN THE BIOLOGICAL TREATMENT OF ALZHEIMER DISEASE
MUDr. Roman Jirák, CSc.
(1/2006, Review articles ) - THE TREATMENT OF PSYCHOTIC DEPRESSION – ACUTE AND CONTINUATION DRUG TREATMENT
MUDr. Martin Bareš, MUDr. Miloslav Kopeček
(1/2006, Review articles ) - ANXIOLYTICS AND THEIR MECHANISM OF ACTION
MUDr. Martin Votava, Ph.D., Mgr. Viktoria Agová, prof. MUDr. Miloslav Kršiak, DrSc.
(4/2005, Review articles ) - Venlafaxin s prodlouženým uvolňováním v ambulantní praxi
MUDr. Luboš Janů, Ph.D.
(1/2006, Outpatient psychiatry ) - TREATMENT OF DEPRESSION WITH ANXIETY AND INSOMNIA
MUDr. Jiřina Kosová
(1/2007, Review articles ) - New possibilities of treatment of ADHD in Slovakia
MUDr. Ján Šuba
(3/2009, Review articles ) - BEHAVIORAL DISTURBANCES IN DEMENTIA
MUDr. Martin Brunovský, Ph.D.
(2/2006, Review articles ) - PHARMACOTHERAPEUTIC OPTIONS IN DEPRESSION
prof. MUDr. Eva Češková, CSc.
(5/2005, Review articles ) - NEW TREATMENT POSSIBILITIES FOR BIPOLAR DEPRESSION
prof. MUDr. Eva Češková, CSc.
(3/2006, Review articles ) - Psychosomatic and psychosocial issues of cardiovascular diseases
prof. MUDr. Jaroslav Šimon, DrSc.
(1/2004, Review articles ) - ATYPICAL ANTIPSYCHOTICS IN TREATMENT RESISTANT DEPRESSION
MUDr. Dagmar Seifertová, CSc., MUDr. Martin Bareš, Ph.D., MUDr. Milan Kopeček
(3/2006, Review articles ) - DEPRESSION, CORONARY ARTERY DISEASE, AND MYOCARDIAL INFARCTION
MUDr. Jiří Podlipný, MUDr. Zdeněk Hess
(4/2006, Review articles ) - A surprising effect of memantine on the progression of Alzheimer‘s disease
MUDr. Jan Kolouch, CSc., MUDr. František Koukolík, DrSc., MUDr. Barbora Balíková
(4/2010, Original articles & case reports )
- Therapeutic advances in hereditary muscular disorders
MUDr. Stanislav Voháňka, CSc., MBA
(3/2011, Review articles ) - Alpha-lipoic acid and neuropatic pain
MUDr. Pavlína Nosková, Ph.D.
(1/2020, From the boundary of neurology ) - GENETIKA PARKINSONOVEJ CHOROBY
MUDr. Pavel Ressner, MUDr. Katarína Kollárová, prof. MUDr. Petr Kaňovský, CSc.
(6/2007, Review articles ) - Pompe disease – clinical case report
MUDr. Ing. Ivana Patáková, CSc.
(6/2014, Case reports ) - Statins and myopathy
prof. MUDr. Zdeněk Ambler, DrSc. †
(6/2013, Review articles ) - Peripheral neuropathy and hepatitis C
prof. MUDr. Zdeněk Ambler, DrSc.
(3/2013, Review articles ) - New in pharmacotherapy of dementia
MUDr. Martin Vališ, Ph.D., MUDr. Dita Kalnická
(1/2011, Review articles ) - Clinical and genetic heterogenity of dopa-responsive dystonia
MUDr. Ján Necpál
(3/2015, Video case reports ) - Pompe disease – pathogenesis, clinical features, diagnosis and enzyme replacement therapy
doc. MUDr. Peter Špalek, PhD.
(1/2009, Review articles ) - Účinnost a snášenlivost galantaminu v léčbě Alzheimerovy nemoci
doc. MUDr. Vladimír Pidrman, Ph.D., MUDr. Klára Látalová, , RNDr. Ing. Karel Chroust, Ph.D.
(5/2006, Review articles ) - Glycogen storage disease type II (GSD II, Pompe disease). Current diagnostic and therapeutic options. Clinical case report
MUDr. Věra Malinová
(5/2010, Review articles ) - Importance of early diagnosis and treatment in the life perspective of patients with multiple sclerosis
doc. MUDr. Jan Mareš, Ph.D.
(5/2012, Review articles ) - Pyridoxine-dependent epilepsy – new trends in diagnosis and treatment
MUDr. Lia Elstnerová, doc. RNDr. Lenka Fajkusová, CSc., MUDr. Štefania Rusnáková, doc. MUDr. Hana Ošlejšková, Ph.D., Mgr. Eva Jansová, Ph.D., Mgr. Pavla Šultesová, doc. MUDr. Dalibor Valík, Ph.D.
(5/2010, Review articles ) - Ideopathic generalized epilepsies
doc. MUDr. Hana Ošlejšková, Ph.D., MUDr. Štefánia Aulická
(4/2014, Review articles ) - Spinal muscular atrophy – diagnostics, therapy, research
RNDr. Petra Hedvičáková, MUDr. Jana Haberlová, Ph.D., MUDr. Alžběta Slabá, MUDr. Tereza Doušová
(6/2016, Main topic ) - Treatment of Parkinson’s disease
prof. MUDr. Ivan Rektor, CSc.
(6/2009, Main topic ) - NEUROPATICKÁ BOLEST – MECHANIZMUS, PŘÍČINY A MOŽNOSTI FARMAKOTERAPIE
prof. MUDr. Zdeněk Ambler, DrSc.
(2/2007, Review articles ) - INHIBITORY CHOLINESTERÁZ V LÉČBĚ ALZHEIMEROVY NEMOCI
MUDr. Martin Brunovský, Ph.D.
(2/2007, Review articles ) - Metoda kontinuálního sledování spektrálních pásem EEG signálu
Mgr. Jiří Donát, prof. MUDr. Josef Faber, DrSc.
(1/2005, Case reports ) - Neurological complications of cancer immunotherapy
prof. MUDr. Ivana Štětkářová, CSc., MHA, FEAN
(5/2023, Main topic ) - Diabetická polyneuropatia
MUDr. Gabriel Hajaš, PhD.
(3/2018, Main topic ) - Pompe disease – case report of the juvenile form
MUDr. Katarína Okáľová, PhD., Mgr. Slavomíra Mattošová, doc. MUDr. Ján Chandoga CSc., MUDr. Viera Holecová
(1/2015, Case reports ) - Deprese u neurologických onemocnění: výskyt a její léčba
MUDr. Sylva Racková
(3/2018, From the boundary of neurology ) - Pompe‘s disease in the Czech Republic – blood-screening project in risk patients using a „dried blood spot“
doc. MUDr. Hana Ošlejšková Ph.D., MUDr. Štefania Rusnáková, MUDr. Stanislav Voháňka, CSc. MBA, MUDr. Eva Slouková
(2/2009, Review articles ) - Some biological and biochemical markers of multiple sclerosis
MUDr. Daniel Čierny, prof. MUDr. Egon Kurča, PhD., MUDr. Jozef Michalik, prof. RNDr. Ján Lehotský, DrSc.
(2/2014, Main topic ) - Friedrich Heinrich Lewy, his corpuscles and their illnesses
prof. MUDr. Petr Kaňovský, CSc., prof. MUDr. Ing. Petr Hluštík, Ph.D., MUDr. Kateřina Menšíková, Ph.D.
(4/2016, From the history of neurology ) - The late-onset form of Pompe disease
MUDr. Radka Mišurová, MUDr. Věra Malinová
(4/2021, Case reports ) - Register a epidemiológia spinálnej a bulbárnej muskulárnej atrofie na Slovensku - komentář ke článku: P. Ridzoňa Kennedyho nemoc (bulbospinální svalová atrofie)
Doc. MUDr. Peter Špalek, PhD., Mgr. Hana Zelinková, MUDr. Petra Jungová
(1/2017, Comments ) - Effects of drugs on neuromuscular junction
MUDr. Stanislav Voháňka, CSc., MBA
(1/2017, Main topic ) - Alzheimer’s disease and mild cognitive impairment: diagnosis and treatment
MUDr. David Doležil, Ph.D. , RNDr. Daniela Řípová, CSc., doc. MUDr. Aleš Bartoš, Ph.D., MUDr. Linda Čechová
(3/2011, Review articles ) - Chemotherapy-induced polyneuropathy
MUDr. Jana Raputová, MUDr. Eva Vlčková, Ph.D., MUDr. Lenka Šmardová, MUDr. Aneta Rajdová, doc. MUDr. Andrea Janíková, Ph.D.
(1/2017, Main topic ) - Statin myopathy
Prof. MUDr. Josef Bednařík, CSc., MUDr. Eva Vlčková, Ph.D., MUDr. Tomáš Horák
(1/2017, Main topic )
- CURRENT VIEW ON THE PATHOGENESIS AND MANAGEMENT OF ATOPIC DERMATITIS
MUDr. Dušan Buchvald Ph.D.
(2/2005, Review articles ) - INFLUENZA IN CHILDREN
MUDr. Zuzana Blechová
(6/2007, Review articles ) - Topical immunomodulators in the treatment of atopic dermatitis
prof. MUDr. Jagienka Jautová, PhD., MBA, MUDr. Janette Baloghová, PhD.
(3/2009, Drugs & drug classes ) - Alimentary methaemoglobinemia
prof. MUDr. Karol Králinský, PhD., MUDr. Michaela Mečiaková, PhD., MPH
(1/2014, Original articles & Case reports ) - Atopic dermatitis – what´s new?
Doc. MUDr. Růžena Pánková, CSc.
(5/2015, Review articles ) - CHRONIC ABDOMINAL PAIN IN CHILDREN
MUDr. Vladimír Volf, Ph.D.
(3/2006, Review articles ) - FOLIC ACID AND CONGENITAL ANOMALIES
prof. MUDr. László Kovács, DrSc., MPH, MUDr. Lucia Šabová
(1/2008, Review articles ) - We have a daughter or not? Androgen insensivity syndrome
MUDr. Silvia Bajová, MUDr. Jitka Kytnarová, doc. MUDr. Alice Baxová, doc. MUDr. Radim Kočvara, Ph.D., MUDr. Blanka Zlatohlávková, Ph.D., MUDr. Rachel Paslerová, prof. MUDr. Richard Plavka, CSc.
(5/2014, Original articles & Case reports )
- Benign prostatic hyperplasia – latest pharmacotherapy options, risks and limitations of treatment
MUDr. Barbora Žemličková, MUDr. Marcela Čechová
(4/2019, Review articles ) - The actual pharmacotherapy benign hyperplasia according to EAU Guidelines
MUDr. Aleš Horák
(3/2021, Review articles ) - Renal carcinoma and immunotherapy
MUDr. Alexandr Poprach, Ph.D., MUDr. Radek Lakomy, Ph.D.
(2/2017, Review articles ) - BENIGN PROSTATE HYPERTROPHY AND CONTEMPORARY TREND IN THE TREATMENT
doc. MUDr. Milan Hora, Ph.D., MUDr. Jiří Klečka
(3/2007, Review articles ) - PARP inhibitors in treating metastatic castration-resistant prostate cancer
MUDr. Igor Richter, Ph.D., doc. MUDr. Josef Dvořák, Ph.D., MUDr. Vladimír Šámal, Ph.D., MUDr. Jiří Bartoš, MBA, MUDr. Sofya Al-Samsam
(3/2023, Review articles ) - PROSTATIC SYNDROME – SYNDROME OF CHRONIC PELVIC PAIN
MUDr. Kamil Belej, FEBU
(4/2007, Review articles ) - NUTRITION FACTORS IN ETIOPATHOGENESIS OF PROSTATE CANCER
doc. MUDr. Ladislav Jarolím, CSc., doc. MUDr. Ivan Kawaciuk, CSc., MUDr. Matúš Chocholatý, MUDr. Marek Schmidt, FEBU, MUDr. Štěpán Veselý, Ph.D
(4/2007, Review articles ) - PHARMACOLOGICAL TREATMENT OF OVERACTIVE BLADDER (OAB) AND URGE URINARY INCONTINENCE
MUDr. Radovan Vrtal, doc. MUDr. Vladimír Študent, Ph.D., MUDr. Aleš Vidlář
(4/2007, Review articles ) - HORMONAL REGULATIONS AND POSSIBILITIES OF INTERVENTION IN PROSTATE CANCER TREATMENT
MUDr. Kamil Belej, FEBU, , MUDr. Ondřej Kaplan
(1/2008, Review articles ) - Management of treatment-related adverse effects in renal cell carcinoma
MUDr. Martin Matějů, Ph.D., MUDr. Michal Zubaľ
(1/2024, From the frontier of urology ) - ERECTILE DYSFUNCTION – NEW PREFERENCES IN TREATMENT?
MUDr. Libor Zámečník, FEBU
(1/2008, Review articles ) - Conservative therapy of non-neurogenic lower urinary tract dysfunctions
MUDr. Miroslav Záleský, Ph.D.
(2/2021, Review articles ) - Drug interactions in urology – what to watch out for
PharmDr. Josef Suchopár, MUDr. Michal Prokeš, Štěpán Suchopár
(2/2020, Drug interaction ) - OBESITY, ADIPOCYTOKINES AND PROSTATE CANCER
MUDr. Daniel Housa
(1/2007, Review articles ) - Drug interactions of medications used in the therapy of erectile dysfunction with dietary supplements
PharmDr. Josef Suchopár, Mgr. Štěpán Suchopár, MUDr. Michal Prokeš
(2/2023, Drug interaction ) - Role of alpha blockers in treating obstructive uropathy
MUDr. Roman Staněk
(4/2020, Review articles ) - COMBINATION DRUG THERAPY IN MEN WITH LOWER URINARY TRACT SYMPTOMS: CONTEMPORARY STATUS
doc. MUDr. Jozef Marenčák, PhD.
(5-6/2007, Review articles )
- Inhibition ALK and ROS1 in the treatment of metastatic non-small lung cancer – new treatment options and recommendations
MUDr. Lucia Denková
(1/2021, Main topic ) - Management of pacients with CML resistant or intolerant to tyrosine kinase inhibitor – imatinib
MUDr. Eva Mikušková, MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Juraj Halička, MUDr. Ľubica Váleková, PhD., MUDr. Emília Flochová, PhD.
(4/2012, Topic of the year ) - Primary myelofibrosis – current view of pathophysiology, prognosis and treatment
Prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(5/2018, Spectrum ) - Treatment of EGFR- mutated non-small cell lung cancer – update
MUDr. Gabriela Chowaniecová, prof. MUDr. Dalibor Ondruš, DrSc.
(1/2021, Main topic ) - Molecular Testing for Selection of Patients With Lung Cancer for Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors
doc. MUDr. Peter Beržinec, CSc.
(6/2014, Information & comments ) - SYSTEMIC TREATMENT FOR ADVANCED HEPATOCELLULAR CANCER
MUDr. Tomáš Šálek, MUDr. Radovan Barilla, PhD.
(1/2008, Review articles ) - Targeted biological therapy for lung cancer – current status and perspectives
doc. MUDr. Peter Beržinec, CSc.
(1/2011, Review articles ) - Current treatment options for BRAF mutant metastatic colorectal cancer
MUDr. Radovan Barila, PhD., MUDr. Igor Andrašina, CSc.
(1/2022, Main topic ) - Monoclonal antibodies in treatment of multiple myeloma
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(5/2016, Spectrum ) - Gastrointestinal stromal tumors
MUDr. Jozef Šufliarsky, PhD.
(1/2011, Review articles ) - Lymphoma biologic therapy
MUDr. Andrej Vranovský, PhD.
(1/2011, Review articles ) - Biological treatment and chronic myeloid leukemia
prof. MUDr. Elena Tóthová, CSc.
(1/2011, Review articles ) - Current possibilities of treatment of chronic B-lymphocytic leukemia in Slovakia and world
Prof. MUDr. Mikuláš Hrubiško, CSc.
(1/2022, Review articles ) - Radium 223Ra in the treatment of bone malignancies
prof. MUDr. Ján Kliment, CSc., MUDr. Hubert Poláček, Ph.D., doc. MUDr. Ivan Režňák, CSc.
(5/2016, Review articles ) - Chronic lymphocytic leukemia - how to treat a patient with relapsed or refractory disease in the era of signaling pathway inhibitors
MUDr. Firas Farkaš, PhD.
(1/2022, Case reports ) - Systemic treatment of neuroendocrine tumours
MUDr. Katarína Štefániková
(5/2021, Main topic ) - Impact of CDK 4/6 inhibitors on overall survival of patients with advanced breast cancer – in the light of new data
MUDr. Bibiána Vertáková Krakovská, PhD.
(2/2024, Company information ) - mTOR inhibitors in the treatment of advanced renal cell carcinoma
MUDr. Radovan Barilla, PhD., MUDr. Zuzana Syčová-Milá
(1/2009, Review articles ) - Current recommendations for bisphosphonates therapy in cancer patients
prof. MUDr. Stanislav Špánik, CSc., MUDr. Beata Špániková, PhD.
(6/2013, Review articles ) - Essential thrombocythemia
doc. MUDr. Martin Mistrík, PhD., MUDr. Zuzana Sninská, PhD., MUDr. Antónia Hatalová, MUDr. Denisa Jankovičová, MUDr. Tatiana Prigancová, doc. MUDr. Angelika Bátorová, PhD.
(6/2013, Review articles ) - An update in breast cancer treatment
MUDr. Markéta Palácová
(4/2007, Review articles ) - Treatment of HR+, HER2- advanced/metastatic breast cancer according to ESO-ESMO recommendations ABC 5
MUDr. Soňa Johnová, MUDr. Soňa Huľová
(2/2021, Review articles ) - Chromosomal rearrangements in lung adenocarcinoma – new treatment options
RNDr. Katarína Hlinková
(3/2014, Review articles ) - Future of treatment of multiple myeloma
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(6/2013, Focus ) - Perspective of radiotherapy in the treatment of malignant melanoma
MUDr. Margita Pobijaková
(6/2016, Main topic ) - Review of of pharmacotherapy of metastatic melanoma
MUDr. Slavomír Urbanček, PhD.
(6/2016, Main topic ) - Management of adverse reactions in treatment with mTOR and CDK4/6 inhibitors
MUDr. Branislav Bystrický, PhD., MPH
(2/2019, Review articles ) - Molecular markers of targeted therapy in oncology malignancies
RNDr. Katarína Hlinková
(2/2010, Review articles ) - Gastrointestinal toxicity, hepatotoxicity and nephrotoxicity of targeted treatment
MUDr. Branislav Bystrický, MUDr. Alexandra Szabová
(1/2013, Main topic ) - How to improve the first line treatment of NSCLC with EGFR mutation?
doc. MUDr. Peter Beržinec, CSc.
(6/2016, Review articles ) - News in the immunotherapy of nonmetastatic non-small-cell lung cancer
MUDr. Lenka Medvecová
(1/2023, Main topic ) - Pneumotoxicity of molecularly targeted anticancer drugs
doc. MUDr. Peter Beržinec, CSc.
(1/2013, Main topic ) - Immune checkpoint inhibitors in non-small cell lung cancer therapy
MUDr. Mária Černá, CSc.
(6/2015, Main topic ) - Treatment of ALK-rearranged non-small cell lung cancer
MUDr. Zuzana Pribulová
(6/2015, Main topic ) - Myelofibrosis – diagnosis, management, new treatment options
MUDr. Anna Vallová
(6/2015, Review articles ) - Diagnosis of chronic myeloid leukemia
MUDr. Ľudmila Demitrovičová, MUDr. Lucia Copáková, MUDr. Eva Mikušková, Mgr. Michaela Leitnerová
(2/2012, Topic of the year ) - SYSTEMIC THERAPY OF NEUROENDOCRINE TUMORS
MUDr. Tomáš Šálek
(4/2006, Review articles ) - Current opinions on chemotherapy for prostate cancer
doc. MUDr. Ján Ľupták, PhD.
(3/2011, Review articles ) - Poly (ADP-ribose) polymerase inhibitors in the treatment of ovarian cancer
MUDr. Michaela Sojáková, PhD.
(5/2017, Review articles ) - Checkpoint inhibitors in treatment of malignant lymphoma
MUDr. Barbora Kašperová
(3/2019, Review articles ) - Immunotherapy and targeted treatment for metastatic, castration-resistant prostate cancer
MUDr. Ján Slopovský, JUDr. MUDr. Patrik Palacka, PhD., MPH, MBA, LL.M.
(4/2022, Main topic ) - Immunotherapy in prostate cancer
MUDr. Katarína Rejleková, PhD.
(5/2020, Review articles ) - Future of treatment of chronic myeloid leukemia (CML)
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(5/2012, Main topic ) - Position of 4/6 cyclin-dependent kinase inhibitors in the 1st line of treatment of metastatic breast cancer
MUDr. Katarína Krajcsovics, PhD.
(4/2019, Review articles ) - Myelofibróza – posúdenie nových liečebných možností
MUDr. Antónia Hatalová
(5/2012, Editorial ) - Place of bosutinib in the therapy of chronic myeloid leukemia
doc. MUDr. Martin Mistrík, PhD., MUDr. Zuzana Sninská, PhD., doc. MUDr. Angelika Bátorová, PhD.
(3/2016, Drugs & drug classes ) - Treatment of patients with metastatic renal cancer after treatment with tyrosine kinase inhibitors
MUDr. Mária Rečková, PhD.
(4/2019, Review articles ) - Systemic therapy of metastatic melanoma
MUDr. Tomáš Šálek
(6/2021, Review articles ) - WALDENSTRÖM‘S MACROGLOBULINEMIA – EPIDEMIOLOGY, ETHIOPATOGENESIS, DIAGNOSTIC AND TREATMENT
prof. MUDr. Elena Tóthová, CSc.
(5/2008, Review articles ) - New mechanism of action in the treatment of renal cell carcinoma: m-TOR – a novel target
MUDr. Hana Študentová, prof. MUDr. Bohuslav Melichar, Ph.D.
(5/2010, Review articles ) - First line treatment of metastatic renal cell cancer in 2014
MUDr. Mária Rečková
(4/2014, Main topic ) - Treatment of metastatic clear cell renal cell carcinoma after failure of first-line treatment
MUDr. Marián Streško, PhD.
(4/2014, Main topic ) - HIF inhibitors and glutaminase inhibitors in the treatment of advanced renal cell carcinoma
MUDr. Zuzana Tomčová
(3/2024, Main topic ) - ELN recommendations for management of CML patients 2013
doc. MUDr. Martin Mistrík, PhD., MUDr. Zuzana Sninská, PhD., MUDr. Antónia Hatalová, doc. MUDr. Angelika Bátorová, PhD.
(4/2014, Review articles ) - Pokrok v imunoterapii malígneho melanómu a karcinómu pľúc inhibítormi imunitných kontrolných bodov
MUDr. Róbert Godál
(2/2018, Main topic ) - Nežiaduce účinky imunoterapie a ich manažment
MUDr. Jaroslava Lešková
(2/2018, Main topic ) - Nové perspektívy v liečbe pokročilého a metastatického HR+ HER2- karcinómu prsníka
MUDr. Miroslava Malejčíková, MUDr. Silvia Jurišová
(2/2018, Review articles ) - Optimal first line treatment in advanced/metastatic renal carcinoma-immunotherapy, targeted therapy, combinations
MUDr. Katarína Rejleková, PhD.
(6/2020, Review articles ) - The incidence and management of side effects of tyrosinekinase inhibitors for treatment of chronic myeloid leukemia
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(1/2015, Review articles ) - Dual inhibition after failure of NSAI as a solution to hormone therapy resistance
MUDr. Bibiána Vertáková Krakovská, PhD.
(1/2015, Review articles ) - Thyroid cancer
MUDr. Jana Ďurková
(1/2015, Review articles ) - Postavenie inhíbitorov aromatázy v adjuvantnej liečbe potmenopauzálnych žien s hormonálne pozitívnym karcinómom prsníka
MUDr. Jana Obertová
(2/2009, Review articles ) - The role of PARP inhibitors in the treatment of breast cancer
MUDr. Eliška Volochová, MUDr. Marián Streško, PhD.
(2/2022, Main topic ) - Optimal management of patients with breast cancer after progression on CDK4/6 inhibitors.
MUDr. Filip Kohútek, PhD., MUDr. Branislav Bystrický, PhD., MPH
(2/2022, Main topic ) - Polycytémia vera – súčasný pohľad na diagnostiku a liečbu
MUDr. Antónia Hatalová, PhD., MUDr. Jana Malinová, doc. MUDr. Martin Mistrík, PhD., prof. MUDr. Angelika Bátorová, CSc.
(3/2018, Spectrum ) - How do we look at CDK4/6 inhibitors in palliative treatment today
MUDr. Miroslava Malejčíková
(2/2022, Main topic ) - Genetic perspectives in prediction of cytostatic toxicity
prof. MUDr. László Kovács, DrSc., MPH, MUDr. Sabína Šufliarska, MUDr. Alica Dzurenková, doc. MUDr. Beáta Mladosievičová, CSc., RNDr. Gabriel Minárik, PhD.
(4/2009, Review articles ) - Daratumumab v kombinovanej liečbe mnohopočetného myelómu
MUDr. Ľubica Harvanová, PhD., doc. MUDr. Martin Mistrík, PhD., prof. MUDr. Angelika Bátorová, PhD.
(3/2018, Drugs & drug classes ) - Pemetrexed - antifolate cytostatic drug for treatment of malignant pleural mesothelioma and non-small cell lung cancer
doc. PharmDr. Juraj Sýkora, CSc.
(4/2009, Drugs & drug classes ) - Advances in the treatment of triple- negative breast cancer
MUDr. Lea Balážová, doc. MUDr. Igor Andrašina, CSc.
(5/2022, Review articles ) - BIOPHARMACEUTICALS IN ONCOLOGY
doc. PharmDr. Juraj Sýkora, CSc.
(3/2008, Review articles ) - Skin toxicity of EGFR inhibitors
MUDr. Katarína Poláková, PhD.
(6/2016, Review articles ) - Immunotherapy for lung cancer
doc. MUDr. Peter Beržinec, CSc.
(4/2016, Main topic ) - The efect of CDK 4/6 inhibition on overal survival in metastatic breast cancer
MUDr. Bibiána Vertáková Krakovská, PhD.
(2/2020, Review articles ) - 11 11TH TH CENTRAL EUROPEAN LUNG CANCER CONFERENCE
doc. MUDr. Peter Beržinec, CSc.
(3/2008, Events ) - Treatment alternatives in newly diagnosed patients with chronic myeloid leukemia
MUDr. Zuzana Sninská, PhD.
(3/2012, Topic of the year ) - Immune therapy of metastatic renal cell carcinoma
MUDr. Michal Chovanec, PhD.
(4/2016, Main topic ) - Chronic myeloid leukemia and its treatment in patients with repeated intolerance of tyrosine kinase inhibitors
MUDr. Radoslav Greksák, PhD.
(2/2020, Case reports ) - Non small-cell lung cancer and treatment options after tyrosine kinase inhibitors failure in the first line
MUDr. Gabriela Chowaniecová
(5/2014, Original articles & case reports ) - Publikujeme v zahraničí
(1/2012, Information & comments ) - CHEMOPREVENTION OF BREAST CANCER
prof. MUDr. Ľudovít M. Jurga, DrSc., prof. MUDr. Myrón Malý, CSc.
(5/2007, Review articles ) - Therapy for chronic myeloid leukemia: Past, present and future
prof. MUDr. Elena Tóthová, CSc.
(1/2012, Topic of the year ) - TREATMENT OF CHRONIC MYELOID LEUKEMIA IN KHAT BRATISLAVA DURING 2002 – 2007
doc. MUDr. Martin Mistrík, PhD., MUDr. Zuzana Sninská, MUDr. Eva Demečková
(6/2008, Original articles ) - Decision-making algorithm in the therapy of patients with advanced malignant melanoma
MUDr. Silvia Jurišová, PhD.
(1/2024, Review articles ) - PARP inhibitors
prof. MUDr. Stanislav Špánik, CSc.
(6/2010, Review articles ) - Changes of bone mineral density in patients with testicular cancer
doc. MUDr. Jozef Mardiak, CSc., prof. MUDr. Juraj Payer, CSc., MUDr. Beata Špániková
(6/2012, Main topic ) - New trends in diagnosis and treatment of essential thrombocythemia and myelofibrosis
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(6/2012, Review articles ) - Treatment of indolent B-cell lymphomas
MUDr. Veronika Ballová
(2/2014, Main topic ) - Ribociclib, inhibitor of cyclin-dependent kinases 4 and 6, in the treatment of HR+/HER2 - advanced breast cancer
MUDr. Mária Rečková
(1/2017, Drugs & drug classes ) - Palbociclib in the treatment of advanced breast cancer
MUDr. Branislav Bystrický
(1/2017, Drugs & drug classes ) - The role of PARP inhibitors in the treatment of ovarian cancer
doc. MUDr. Lýdia Heľpianska, CSc.
(4/2021, Main topic ) - The role of targeted therapy in the treatment of renal cell carcinoma
doc. MUDr. Jozef Mardiak, CSc.
(5/2009, Review articles ) - Publikujeme v zahraničí
(1/2017, Information & comments ) - Updated ESMO recommendations for the treatment of newly diagnosed ovarian epithelial carcinoma
doc. MUDr. Lýdia Heľpianska, CSc.
(3/2022, Review articles ) - Management of chronic myeloid leukemia after failure of second generation tyrosine kinase inhibitors
MUDr. Katarína Slezáková, PhD., MUDr. Zuzana Sninská, PhD., doc. MUDr. Peter Rohoň, PhD., prof. MUDr. Angelika Bátorová, PhD.
(3/2022, Review articles ) - Systemic mastocytosis – diagnostics and perspectives of therapy
MUDr. Ján Lazúr
(6/2019, Review articles ) - DID THE INTRODUCTION OF TARGETED THERAPY LIMIT THE IMPORTANCE OF CYTOSTATIC TREATMENT ?
prof. MUDr. Pavel Klener, DrSc.
(6/2007, Review articles ) - Nivolumab in the renal cell carcinoma treatment
MUDr. Bc. Patrik Palacka, PhD., MPH, MBA, LL.M., Vladimíra Baranová
(1/2018, Main topic ) - THE IMPORTANCE OF LABORATORY DIAGNOSTICS OF HUMAN PAPILLOMAVIRUSES
MUDr. Georgína Kolníková, MUDr. Peter Kolník
(4/2008, Review articles ) - IMMUNOHISTOCHEMICAL ANALYSIS OF KOMPLEX DIAGNOSTIC OF MALIGNANT LUNG TUMOURS
doc. MUDr. František Ondriaš, CSc., MUDr. Jana Rampalová, MUDr. Petya Marinova, Bc. Silvia Orthová, MUDr. Andrea Jašková, Mgr. Zuzana Gubrij
(4/2008, Review articles ) - News in systemic treatment of ovarian cancer
MUDr. Michaela Sojáková, PhD.
(6/2018, Review articles ) - Principles of hormonal therapy and chemotherapy in the treatment of metastatic HR+, HER2- breast cancer
MUDr. Miroslava Malejčíková
(6/2018, Review articles ) - Management of skin toxicities associated with epidermal growth factor inhibitor cetuximab in combination with chemotherapy or radiotherapy
MUDr. Katarína Poláková
(6/2011, Review articles )
- Cutaneous adverse effects of targeted oncologic therapies
MUDr. Katarína Poláková, PhD.
(1/2016, Topic of the year ) - Atypical fibrous histiocytoma of the skin
MUDr., PhDr. Vladimír Bartoš, PhD., MPH
(1/2021, Case reports ) - Cardiovascular diseases and psoriasis
MUDr. Zuzana Baranová, PhD.
(3/2016, Review articles ) - Review of of pharmacotherapy of metastatic melanoma
MUDr. Slavomír Urbanček, PhD.
(4/2016, Topic of the year ) - PEELING AND PRINCIPLES OF THE CORRECT USE
MUDr. Lucie Růžičková Jarešová
(3/2008, Review articles ) - THE OPTIONS OF HORMONAL TREATMENT OF ACNE
doc. MUDr. Jarmila Rulcová, CSc.
(3-4/2007, Review articles ) - Tacrolimus in treatment of atopic dermatitis
MUDr. Janette Baloghová, PhD., prof. MUDr. Jagienka Jautová, PhD.
(3/2011, Drugs & drug classes ) - Subacute cutaneous lupus erythematodes in a patient with SHARP syndrome – case report
MUDr. Barbora Gulánová, MUDr. Martina Part, PhD., prof. MUDr. Mária Šimaljaková, PhD, MHA
(2/2017, Original articles & case reports ) - Skin immune-mediated adverse reactions in the biological treatment of chronic inflammatory diseases
MUDr. Karolína Vorčáková, PhD., prof. MUDr. Juraj Péč, CSc.
(1/2019, Review articles ) - Schnitzler syndrome – chronic urticaria + monoclonal gammopathy IgM + osteolytic-osteosklerotic bone changes
prof. MUDr. Zdeněk Adam, CSc., MUDr. Luděk Pour, Ph.D., MUDr. Marta Krejčí, Ph.D., prof. MUDr. Roman Hájek, CSc., MUDr. Jiří Neubauer, MUDr. Jiří Prášek, CSc.
(2/2011, Original articles & case reports ) - BIOLOGICA TREATMENT OF PSORIATIC ARTHRITIS
MUDr. Liliana Šedová, MUDr. Jiří Štolfa
(2/2007, Interdisciplinary overviews ) - Immunohistochemical expression of smooth muscle actin in basal cell carcinoma of the skin
MUDr. Jana Doboszová, MUDr. Vladimír Bartoš, PhD.
(3/2014, Original articles & case reports ) - Atopic dermatitis – what´s new?
Doc. MUDr. Růžena Pánková, CSc.
(1/2015, Review articles ) - Advers skin effect of target therapy in oncology
MUDr. Katarína Poláková, PhD.
(4/2018, Review articles ) - Acne-like rash and another skin toxicities associated with administration of HER1/EGFR inhibitors
MUDr. Katarína Poláková, PhD.
(1/2010, Review articles ) - Upadacitinib in the treatment of atopic dermatitis
MUDr. Karolína Vorčáková, PhD.
(2/2023, Drugs and drug groups )
- POSITION OF ANGIOTENSIN 2-RECEPTOR BLOCKERS IN THE TREATMENTS OF ARTERIAL HYPERTENSION AND CURRENT MEDICINE
doc. MUDr. Marian Sninčák, PhD.
(3-4/2007, clearly ) - ANTIDEPRESIVA V LÉČBĚ SEXUÁLNÍCH DYSFUNKCÍ U ŽEN
doc. MUDr. Alexandra Žourková, CSc.
(1/2007, clearly ) - EFFECTIVITY AND SAFETY OF COXIBS
doc. MUDr. Jozef Lukáč, CSc., MUDr. Oľga Lukáčová, CSc.
(3-4/2007, clearly ) - OBSESSIVE-COMPULSIVE DISORDER
MUDr. Branislav Moťovský
(3/2008, Review articles ) - DIAGNOSTICS AND TREATMENT OF DEPRESSION IN DIABETES MELLITUS
MUDr. Ľubica Forgáčová, PhD.
(3/2008, Review articles ) - PHARMACOTHERAPY OF BENIGN PROSTATIC HYPERPLASIA, PREVENTION, EFFECTIVE MEDICATIONS, ADVERSE EVENTS
MUDr. Miloš Broďák, MUDr. Lukáš Holub
(2/2007, clearly ) - STATÍNY – MAJÚ DOMINANTNÉ MIESTO V KARDIOVASKULÁRNEJ PREVENCII? LIPIDY ZNIŽUJÚCE A PLEIOTROPNÉ ÚČINKY STATÍNOV
doc. MUDr. Daniel Pella, PhD.
(2/2007, clearly ) - COMBINATION THERAPY FOR HYPERTENSION
Doc. MUDr. Milan Grundmann, CSc., MUDr. Ivana Kacířová
(2/2007, clearly ) - ACE – INHIBITORS AND AT1R – ANTAGONISTS ARE THE FIRST LINE MEDICATION FOR IgA NEPHROPATHY
prof. MUDr. Karel Matoušovic, DrSc.
(2/2008, Drug classes )
- Current opinions on the treatment of glaucoma
prof. MUDr. Gabriela Nosáľová, DrSc., doc. RNDr. Soňa Fraňová, PhD., MUDr. Peter Žiak, PhD., MUDr. Milena Čipkalová, doc. MUDr. Juraj Mokrý, PhD.
(4/2012, Current pharmacotherapy ) - Optimising treatment in Alzheimer’s disease
MUDr. Vanda Franková
(3/2016, Current pharmacotherapy ) - Probiotics, prebiotics, fecal microbiota therapy and inflammatory bowel disease
PharmDr. Monika Fedorová, prof. MVDr. Juraj Pistl, PhD.
(4/2014, Current pharmacotherapy ) - Novel targeted therapeutics in dyslipoproteinemia
PharmDr. Ľubica Lehocká, PhD., PharmDr. Lucia Masaryková, PhD., PharmDr. Anna Oleárová, PhD., MPH, MUDr. Katarína Jurečková
(3-4/2015, Current pharmacotherapy ) - Current possibilities of benign prostatic hyperplasia therapy part I.
doc. RNDr. Magdaléna Fulmeková, CSc., PharmDr. Lucia Masaryková, PharmDr. Ľubica Lehocká, PhD.
(3/2012, Current pharmacotherapy ) - Safe and effective antihypertensive therapy in obesity
PharmDr. Iva Prokopová, Ph.D.
(4/2016, Clinical pharmacy ) - What can statins do in the management of cardiovascular deseases?
MUDr. Marta Filková, prof. MUDr. Ján Murín, CSc.,, MUDr. Miroslav Pernický
(1/2013, Current pharmacotherapy ) - Pathology of folic acid nad pregnancy
MUDr. Michal Koucký
(3/2011, Current pharmacotherapy ) - Rilmenidine use in clinical practice
MUDr. Martin Čaprnda, PhD.
(1/2014, Clinical pharmacy ) - Sitagliptin
Ondřej Krystyník
(1/2011, New medicinal substances ) - Dyslipidémie ako rizikový faktor kardiovaskulárnych ochorení: dôraz na familiárnu hypercholesterolémiu, jej včasnú diagnostiku a terapiu
Doc. PharmDr. Adriana Duriš Adameová, PhD.
(2/2018, Current pharmacotherapy ) - Current Possibilities of Dyslipidema Therapy
doc. RNDr. Magdaléna Fulmeková, CSc., PharmDr. Lucia Masaryková, PharmDr. Ľubica Lehocká, PhD.
(2/2011, Current pharmacotherapy ) - Huperzine A and other natural substances in treating Alzheimer's disease
PharmDr. Jan Martin, Mgr. Zuzana Kršková, doc. RNDr. Jaroslav Dušek, CSc.
(2/2011, Phytotherapy ) - Safety treatment with statins
prof. MUDr. RNDr. Rudolf Pullmann, PhD.
(4/2013, Clinical pharmacy ) - Current trends in treatment of atopic dermatitis – a minimum for pharmacists
MUDr. Petra Brodská, Ph.D.
(3/2023, Current pharmacotherapy )
- Idelvion (Albutrepenonacog Alfa) − rekombinantný koagulačný faktor IX s predĺženým účinkom v liečbe hemofílie B
MUDr. Tomáš Šimurda, PhD., MUDr. Miroslava Dobrotová, PhD., Prof. MUDr. Ján Staško, PhD., prof. MUDr. Peter Kubisz, DrSc.
(1/2018, Drugs & drug classes ) - Retinal vein occlusion
prof. MUDr. Peter Kubisz, DrSc., MUDr. Juraj Chudej, MUDr. Juraj Sokol, MUDr. Radoslava Šimonová1, MUDr. Katarína Kabačová, doc. MUDr. Ján Staško, PhD., mim. prof.
(3-4/2012, Review articles ) - Current status and perspectives of pharmacotherapy of pulmonary arterial hypertension
MUDr. Pavel Jansa
(3/2011, Review articles ) - Inhibitors of factors XI and XII
doc. MUDr. Juraj Sokol, PhD., MBA, MUDr. František Nehaj, PhD., MBA, MUDr. Juraj Chudej, PhD., MBA, MUDr. Lenka Lisá, PhD., MUDr. Ľudmila Lineková, MUDr. Ivan Kecskés, MBA, Prof. MUDr. Ján Staško, PhD.
(1/2024, Review articles ) - Plasma levels of proinflammatory kinines in abdominal aortic aneurysm
prof. MUDr. Vladislav Třeška, DrSc., MUDr. Jiří Moláček, PhD., MUDr. Karel Houdek,MUDr. Inka Třešková, MUDr. Andrea Ňaršanská, MUDr. Miroslav Polák, prof.MUDr. Ondřej Topolčan, CSc., Dr. Jindra Vrzalová, PhD., doc.MUDr.Jitka Kočová, CSc.,doc. MUDr. Zbyněk Tonar, PhD.,MUDr. Věra Křížková, PhD., doc. MUDr. Ludmila Boudová, PhD.
(2/2011, Main topic ) - Hemophilia A and risk of inhibitor development – what changed the SIPPET study?
Prof. MUDr. Ján Staško, PhD., MUDr. Juraj Sokol, PhD., MUDr. Lucia Stančiaková, PhD., MUDr. Tomáš Šimurda, MUDr. Pavol Hollý, PhD, prof. MUDr. Peter Kubisz, DrSc.
(3-4/2017, Main topic ) - Acquired hemophilia A
Doc. MUDr. Mária Hulíková, PhD.
(3-4/2017, Main topic )
- The role and importance of measuring fibrinolytic agents uPA and PAI-1 in oncosurgical patients
MUDr. Soňa Huľová, MUDr. Edward Huľo, MUDr. Lucia Rišková, doc. MUDr. Jana Kaťuchová, PhD.
(2-3/2017, Review articles ) - Multivisceral resection as a treatment option for a large gastrointestinal stromal tumor - a case report
MUDr. Monika Miklóšová, doc. MUDr. Jozef Belák, PhD., MUDr. Marián Kudláč, MUDr. Ivan Kováč, PhD.
(1-2/2020, Case report )
- Dexmedetomidine in the prevention of postoperative delirium in cardiac surgery patients
MUDr. Peter Čandík, PhD., MUDr. František Sabol, PhD., doc. MUDr. Pavol Török, CSc., MUDr. Boris Bilý, MUDr. Panayiotis Artemiou, PhD., MUDr. Adrián Kolesár, PhD., MUDr. Viktória Kováčová
(1/2015, Original articles ) - Melatonin and its potential use in anesthesiology and intensive care
MUDr. Peter Čandík, PhD., doc. MUDr. Pavol Török, CSc., MUDr. Adrián Kolesár, PhD., MUDr. Viktória Kováčová, MUDr. Boris Bilý, PhD., doc. MUDr. František Sabol, PhD., MPH
(1/2016, Review articles ) - Premedication and postoperative effects
MUDr. Ľubomíra Romanová, PhD.
(2/2016, Review articles )